Company Profile:
Company Introduction:
Chemo SA is a global pharmaceutical company headquartered in Lugano, Switzerland, and is a key part of the Insud Pharma group. The company specializes in the research, development, manufacturing, and commercialization of active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs). Chemo SA focuses on delivering high-quality generic drugs and biosimilars to the global pharmaceutical market. It operates with an international network of research and development centers, manufacturing plants, and commercial offices, serving customers worldwide.
Business Type:
Chemo SA is both a manufacturer and a trader. It owns and operates manufacturing facilities (factories) for the production of Active Pharmaceutical Ingredients (APIs) and various finished dosage forms. Additionally, it functions as a trader and distributor, selling its manufactured products globally to other pharmaceutical companies and marketing its own portfolio of generic medicines.
Clarification on Location:
Please note that Chemo SA is headquartered in Lugano, Switzerland. While Chemo SA is a global company and may have commercial activities or a local presence in Turkey, the "Lugano Branch" specifically refers to its primary operations located in Lugano, Switzerland, not in Turkey.
Enterprise Products
CHEMO SA, including its operations managed from the Lugano entity, primarily produces and sells the following products:
Active Pharmaceutical Ingredients (APIs): These are the core chemical substances used in the manufacture of various pharmaceutical drugs. CHEMO SA supplies a diverse range of APIs to other pharmaceutical companies globally, including those operating in Turkey.
Finished Dosage Forms (FDFs): As part of the broader Insud Pharma group, CHEMO SA also develops, manufactures, and markets complete pharmaceutical products. These include generic drugs, branded generics, and biosimilars across numerous therapeutic areas. Such finished products are distributed and sold in various international markets, potentially including Turkey.